Valley Fever Awareness and Vaccine Development and Manufacturing Act of 2024

Cost and committee reports

Official records Congress.gov attaches to H.R. 9942.

• Constitutional authority statementThe sponsor’s statement of where the Constitution gives Congress the power to pass this bill. Statement by Mr. DUARTE, as printed in the Congressional Record (Vol. 170, No. 154, October 8, 2024, Page H5861):
  Article I Section 8 of the U.S. Constitution The single subject of this legislation is: To support the development, licensing, and initial manufacturing of a human vaccine for Valley Fever.
  Source: Congress.gov, Congressional Record October 8, 2024 ↗

  Evidence

  Field in the Congress.gov record

  constitutionalAuthorityStatementText

  Statement length

  189 characters

  Congress.gov bill record

  H.R. 9942, 118th Congress

  Congress.gov API record

  https://api.congress.gov/v3/bill/118/hr/9942

  Record last updated by Congress.gov

  August 14, 2025

  PORKER copy retrieved

  September 14, 2026

  Stored copy, SHA-256 of the file

  e5b13331ad781e14f66d2cd9c4ec827d9106d7bcb5d42137c4cdb94a85e82807

  PORKER shows the statement exactly as printed, with the page markup removed. It is the sponsor’s claim; it is not a legal finding.

Congress.gov’s record for this bill does not list a CBO cost estimate or a committee report (as of August 14, 2025). Not every bill gets one.

From the Congress.gov bill record for H.R. 9942, last updated August 14, 2025. PORKER’s copy was retrieved September 14, 2026 and is refreshed nightly. Open “Evidence” on any line for the record, field and file fingerprint.